Table 1.
The relationship between FOXK2 and clinicopathologic characteristics in the TCGA cohort.
| Clinicopathologic characteristics | Low expression (%) | High expression (%) | χ2 | P |
|---|---|---|---|---|
| Age (N=505) | 1.149 | 0.284 | ||
| <55 | 175(69.2%) | 163(64.7%) | ||
| ≥55 | 78 (30.8%) | 89(35.3%) | ||
| Gender (N=505) | 0.140 | 0.708 | ||
| Female | 183(72.3%) | 186(73.8%) | ||
| Male | 70(27.7%) | 66(26.2%) | ||
| Histological type (N=505) | 6.455 | 0.091 | ||
| Classical | 181(71.5%) | 177(70.2%) | ||
| Follicular | 57(22.5%) | 45(17.9%) | ||
| Tall Cell | 12(4.7%) | 24(9.5%) | ||
| other | 3(1.2%) | 6(2.4%) | ||
| Tumor size (N=405) | 10.000 | 0.002 | ||
| <2cm | 95(38.6%) | 62(25.3%) | ||
| ≥2cm | 151(61.4%) | 183(74.7%) | ||
| T stage (N=503) | 10.458 | 0.001 | ||
| T1 | 88(34.9%) | 55(21.9%) | ||
| >T1 | 164(65.1%) | 196(78.1%) | ||
| Extrathyroidal invasion (N=487) | 2.493 | 0.114 | ||
| NO | 172(72.0%) | 162(65.3%) | ||
| YES | 67(28.0%) | 86(34.7%) | ||
| Lymph node metastasis (N=455) | 3.689 | 0.055 | ||
| NO | 126 (55.0%) | 104 (46.0%) | ||
| YES | 103 (45.0%) | 122 (54.0%) | ||
| TNM (N=503) | 5.824 | 0.016 | ||
| I-III | 232(92.4%) | 216(85.7%) | ||
| IV | 19(7.6%) | 36(14.3%) |